MAPPING THE EXTRACELLULAR TOPOGRAPHY OF THE ALPHA-CHAIN IN FREE AND IN MEMBRANE-BOUND ACETYLCHOLINE-RECEPTOR BY ANTIBODIES AGAINST OVERLAPPING PEPTIDES SPANNING THE ENTIRE EXTRACELLULAR PARTS OF THE CHAIN
Mz. Atassi et B. Mulacjericevic, MAPPING THE EXTRACELLULAR TOPOGRAPHY OF THE ALPHA-CHAIN IN FREE AND IN MEMBRANE-BOUND ACETYLCHOLINE-RECEPTOR BY ANTIBODIES AGAINST OVERLAPPING PEPTIDES SPANNING THE ENTIRE EXTRACELLULAR PARTS OF THE CHAIN, Journal of protein chemistry, 13(1), 1994, pp. 37-47
The extracellular surface of the a-chain of Torpedo california acetylc
holine receptor (AChR) was mapped for regions that are accessible to b
inding with antibodies against a panel of synthetic overlapping peptid
es which encompassed the entire extracellular parts of the chain. The
binding of the antipeptide antibodies to membrane-bound AChR (mbAChR)
and to isolated, soluble AChR was determined. The specificity of each
antiserum was narrowed down by determining the extent of its cross-rea
ction with the two adjacent peptides that overlap the immunizing pepti
de. With mbAChR, high antibody reactivity was obtained with antisera a
gainst peptides alpha1-16, alpha89-104, alpha158-174, alpha262-276, an
d alpha388-408. Lower, but significant, levels of reactivity were obta
ined with antibodies against peptides alpha67-82, alpha78-93, alpha100
-115, and alpha111-126. On the other hand, free AChR bound high levels
of antibodies against peptides alpha34-49, alpha78-93, alpha134-150,
alpha170-186, and alpha194-210. It also bound moderate levels of antib
odies against peptides alpha262-276 and alpha388-408. Low, yet signifi
cant, levels of binding were exhibited by antibodies against peptides
alpha45-60, alpha111-126, and alpha122-138. These binding studies, whi
ch enabled a comparison of the accessible regions in mbAChR and free A
ChR, revealed that the receptor undergoes considerable changes in conf
ormation upon removal from the cell membrane. The exposed regions foun
d here are discussed in relation to the functional sites of AChR (i.e.
, the acetylcholine binding site, the regions that are recognized by a
nti-AChR antibodies, T-cells and autoimmune responses and the regions
that bind short and long neurotoxins).